Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
The closing price of Palisade Bio Inc (NASDAQ: PALI) was $1.87 for the day, down -11.37% from the previous closing price of $2.11. In other words, the price has decreased by -$11.37 from its previous closing price. On the day, 4.57 million shares were traded. PALI stock price reached its highest trading level at $2.07 during the session, while it also had its lowest trading level at $1.85.
Ratios:
Our analysis of PALI’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.78 and its Current Ratio is at 1.78. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.00.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PALI now has a Market Capitalization of 279010016 and an Enterprise Value of 273622016.
Stock Price History:
The Beta on a monthly basis for PALI is 1.56, which has changed by -0.17982459 over the last 52 weeks, in comparison to a change of 0.12607694 over the same period for the S&P500. Over the past 52 weeks, PALI has reached a high of $3.30, while it has fallen to a 52-week low of $0.53. The 50-Day Moving Average of the stock is 7.56%, while the 200-Day Moving Average is calculated to be 85.01%.
Shares Statistics:
PALI traded an average of 7.81M shares per day over the past three months and 3818880 shares per day over the past ten days. A total of 149.00M shares are outstanding, with a floating share count of 139.74M. Insiders hold about 6.22% of the company’s shares, while institutions hold 28.72% stake in the company. Shares short for PALI as of 1763078400 were 7946168 with a Short Ratio of 1.02, compared to 1760486400 on 5920702. Therefore, it implies a Short% of Shares Outstanding of 7946168 and a Short% of Float of 5.33.
Earnings Estimates
The performance of Palisade Bio Inc (PALI) in the stock market is under the watchful eye of 3.0 analysts actively contributing to its current rating.The consensus estimate for the next quarter is -$0.04, with high estimates of -$0.04 and low estimates of -$0.04.
Analysts are recommending an EPS of between -$0.18 and -$1.11 for the fiscal current year, implying an average EPS of -$0.52. EPS for the following year is -$0.2, with 3.0 analysts recommending between -$0.09 and -$0.35.
